In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Germany's Merck KGaA said it has appointed Jessie English as the vice president of discovery, translational innovation platform immuno-oncology, effective February 16, 2016. 21 January 2016
Biotechnology
Austria-based biotechnology company Themis Bioscience on Tuesday announced the appointment of two new members to leadership roles, Philippe Dro and Christian Mandl. 19 January 2016
Biotechnology
UK biotech firm Centauri Therapeutics said today it has acquired the Alphamer technology for drug discovery and development from Altermune Technologies. 18 January 2016
Pharmaceutical
Swedish Orphan Biovitrum today announced that Birgitte Volck, senior vice president of development and chief medical officer (CMO) of Sobi, will leave the company. 14 January 2016
Biotechnology
Shares in US biotech firm Celgene Corp closed down over 5.5% on Nasdaq Monday after the company named chief operating officer Mark Alles as chief executive effective March 1, and cut its outlook for 2015. 12 January 2016
Pharmaceutical
Switzerland-based Cardiorentis AG said it has raised 60 million Swiss Franc ($60 million) via private investors to advance its Phase III trials for Ularitide, a therapy for acute decompensated heart failure (ADHF), including upcoming regulatory submissions expected in the second half of 2016. 11 January 2016
Pharmaceutical
Israel-based Kitov Pharmaceuticals has appointed Gil Ben-Menachem as vice president business development. 8 January 2016
Biotechnology
Cytos Biotechnology on Friday said the company will be renamed Kuros Biosciences Ltd and that its chief executive Christian Itin will be stepping down from his position. 8 January 2016
Biotechnology
Allogeneic CAR T-cell therapies specialist Cellectis has announced the appointment of Loan Hoang-Sayag to the role of chief medical officer. 8 January 2016
Pharmaceutical
Canadian drug maker Valeant Pharmaceuticals International said it has appointed Howard Schiller as interim chief executive. 7 January 2016
Biotechnology
Genticel on Wednesday named Rémi Palmantier chief scientific officer. 6 January 2016
Pharmaceutical
Shares in Valeant Pharmaceuticals dropped over 10% on December 28 after the company said chief executive Michael Pearson is taking a medical leave with immediate effect. 4 January 2016
Pharmaceutical
British clinical stage drug development company Evgen Pharma has appointed a new chief medical officer, it has been announced. 4 January 2016
Biotechnology
KaloBios Pharmaceuticals, which fired its controversial chief executive Martin Shkreli earlier this month, yesterday announced that, on December 28, 2015, the company submitted a request to Nasdaq requesting an appeal of Nasdaq's decision to delist the company's securities. 30 December 2015
Pharmaceutical
US drugmaker MannKind Corp today announced the appointment of Duane DeSisto as its president and chief executive, effective January 5, 2016, replacing Alfred Mann who has served as interim CEO since November 19, 2015. 24 December 2015
Biotechnology
Dutch human gene therapy specialist uniQure NV has named Dan Soland its chief executive officer. He will succeed Jörn Aldag, who will step down from the role he has held since 2009. 21 December 2015
Pharmaceutical
KaloBios Pharmaceuticals Inc on Monday said that Martin Shkreli was terminated as chief executive officer of the and resigned from his position as a member of the board of directors. 21 December 2015
Pharmaceutical
Ariad Pharmaceuticals named Paris Panayiotopoulos president and chief executive officer, effective January 1, 2016. 21 December 2015
Pharmaceutical
Australian drug company Novogen has appointed Dr James Garner as its new chief executive, it has been announced. 10 December 2015
Biotechnology
Life sciences company Avacta has appointed Tony Gardiner as group chief financial officer, it has been announced. 10 December 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze